Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Allogene Therapeutics Inc (ALLO)

Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Allogene Therapeutics Inc 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 USA

www.allogene.com P: 650-457-2700

Description:

Allogene Therapeutics, Inc. is a clinical-stage immuno-oncology company, primarily focused on the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer.'

Key Statistics

Overview:

Market Capitalization, $K 574,913
Enterprise Value, $K 491,753
Shares Outstanding, K 169,092
Annual Sales, $ 100 K
Annual Net Income, $ -327,270 K
Last Quarter Sales, $ 40 K
Last Quarter Net Income, $ -61,320 K
EBIT, $ -338,940 K
EBITDA, $ -331,550 K
60-Month Beta 0.81
% of Insider Shareholders 27.40%
% of Institutional Shareholders 83.63%
Float, K 122,761
% Float 72.60%
Short Volume Ratio 0.35

Growth:

1-Year Return -36.78%
3-Year Return -89.00%
5-Year Return -88.75%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 69.45%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.43 on 03/14/24
Latest Earnings Date 05/01/24
Earnings Per Share ttm -2.24
EPS Growth vs. Prev Qtr -16.22%
EPS Growth vs. Prev Year 34.85%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ALLO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -53.76%
Return-on-Assets % -43.24%
Profit Margin % -327,269.98%
Debt/Equity 0.00
Price/Sales 6,176.31
Price/Cash Flow N/A
Price/Book 1.14
Book Value/Share 3.48
Interest Coverage -2.85
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar